Cost-Utility Analysis of 1-Year Treatment With Adalimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland
European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-016-2103-4
Full Text
Open PDFAbstract
Available in full text
Date
August 6, 2016
Authors
Publisher
Springer Science and Business Media LLC